Chrepa Vanessa, Austah Obadah, Diogenes Anibal
Department of Endodontics, University of Washington, Seattle, Washington.
Department of Endodontics, University of Texas Health Science Center at San Antonio, San Antonio, Texas; Department of Endodontics, Faculty of Dentistry, King Abdulaziz University at Jeddah, Jeddah, Saudi Arabia.
J Endod. 2017 Feb;43(2):257-262. doi: 10.1016/j.joen.2016.10.026. Epub 2016 Dec 29.
Regenerative endodontic procedures (REPs) are viable alternatives for treating immature teeth, yet these procedures do not predictably lead to pulp-dentin regeneration. A true bioengineering approach for dental pulp regeneration requires the incorporation of a scaffold conducive with the regeneration of the pulp-dentin complex. Several materials have been proposed as scaffolds for REPs; nonetheless, the majority are not eligible for immediate clinical chairside use. Thus, the aim of this study was to evaluate Restylane, a Food and Drug Administration-approved hyaluronic acid-based gel, as possible scaffold for REPs.
Stem cells of the apical papilla (SCAP) were cultured either alone or in mixtures with either Restylane or Matrigel scaffolds. Groups were cultured in basal culture medium for 6, 24, and 72 hours, and cell viability was assessed. For the mineralizing differentiation experiments, groups were cultured in differentiation medium either for 7 days and processed for alkaline phosphatase activity or for 14 days and processed for gene expression by using quantitative reverse-transcription polymerase chain reaction. SCAP in basal medium served as control.
Cell encapsulation in either Restylane or Matrigel demonstrated reduced cell viability compared with control. Nonetheless, cell viability significantly increased in the Restylane group in the course of 3 days, whereas it decreased significantly in the Matrigel group. Restylane promoted significantly greater alkaline phosphatase activity and upregulation of dentin sialophosphoprotein, dentin matrix acidic phosphoprotein-1, and matrix extracellular phosphoglycoprotein, compared with control.
A Food and Drug Administration-approved hyaluronic acid-based injectable gel promoted SCAP survival, mineralization, and differentiation into an odontoblastic phenotype and may be a promising scaffold material for REPs.
再生牙髓治疗程序(REPs)是治疗未成熟牙齿的可行替代方法,但这些程序并不能可预测地导致牙髓-牙本质再生。一种真正的牙髓再生生物工程方法需要引入一种有利于牙髓-牙本质复合体再生的支架。已经提出了几种材料作为REPs的支架;然而,大多数材料不符合即时临床椅旁使用的条件。因此,本研究的目的是评估瑞蓝(Restylane),一种经美国食品药品监督管理局批准的基于透明质酸的凝胶,作为REPs可能的支架。
根尖乳头干细胞(SCAP)单独培养或与瑞蓝或基质胶支架混合培养。将各组在基础培养基中培养6、24和72小时,并评估细胞活力。对于矿化分化实验,将各组在分化培养基中培养7天并进行碱性磷酸酶活性检测,或培养14天并使用定量逆转录聚合酶链反应进行基因表达检测。在基础培养基中的SCAP用作对照。
与对照组相比,在瑞蓝或基质胶中进行细胞包封显示细胞活力降低。尽管如此,瑞蓝组的细胞活力在3天内显著增加,而基质胶组的细胞活力则显著下降。与对照组相比,瑞蓝显著促进了更高的碱性磷酸酶活性以及牙本质涎磷蛋白、牙本质基质酸性磷酸蛋白-1和基质细胞外磷酸糖蛋白的上调。
一种经美国食品药品监督管理局批准的基于透明质酸的可注射凝胶促进了SCAP的存活、矿化以及向成牙本质细胞表型的分化,可能是一种有前途的REPs支架材料。